- Home
- PRGO vs NJR Comparison
PRGO vs NJR Comparison
Compare PRGO & NJR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- NJR
- Stock Information
- Founded
- PRGO 1887
- NJR 1922
- Country
- PRGO Ireland
- NJR United States
- Employees
- PRGO N/A
- NJR N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- NJR Oil/Gas Transmission
- Sector
- PRGO Health Care
- NJR Utilities
- Exchange
- PRGO Nasdaq
- NJR Nasdaq
- Market Cap
- PRGO 3.9B
- NJR N/A
- IPO Year
- PRGO 1991
- NJR N/A
- Fundamental
- Price
- PRGO $25.76
- NJR $46.51
- Analyst Decision
- PRGO Buy
- NJR Hold
- Analyst Count
- PRGO 4
- NJR 4
- Target Price
- PRGO $37.00
- NJR $51.00
- AVG Volume (30 Days)
- PRGO 1.2M
- NJR 527.3K
- Earning Date
- PRGO 11-06-2024
- NJR 02-04-2025
- Dividend Yield
- PRGO 4.29%
- NJR 3.75%
- EPS Growth
- PRGO N/A
- NJR 7.75
- EPS
- PRGO N/A
- NJR 2.92
- Revenue
- PRGO $4,392,000,000.00
- NJR $1,796,539,000.00
- Revenue This Year
- PRGO N/A
- NJR $9.54
- Revenue Next Year
- PRGO $4.51
- NJR $3.86
- P/E Ratio
- PRGO N/A
- NJR $15.76
- Revenue Growth
- PRGO N/A
- NJR N/A
- 52 Week Low
- PRGO $23.89
- NJR $39.44
- 52 Week High
- PRGO $34.60
- NJR $51.95
- Technical
- Relative Strength Index (RSI)
- PRGO 36.42
- NJR 39.12
- Support Level
- PRGO $25.16
- NJR $45.38
- Resistance Level
- PRGO $28.62
- NJR $48.03
- Average True Range (ATR)
- PRGO 0.66
- NJR 0.91
- MACD
- PRGO -0.35
- NJR -0.47
- Stochastic Oscillator
- PRGO 15.79
- NJR 18.17
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.